Copyright
©The Author(s) 2020.
World J Clin Cases. Jan 6, 2020; 8(1): 46-53
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.46
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.46
Item | Time | Pain | Stiff | Dysfunction |
Eucommia-meloxicam group | Before treatment | 16.59 ± 2.13 | 6.84 ± 0.36 | 36.63 ± 4.21 |
After treatment | 7.31 ± 3.14 | 1.69 ± 0.23 | 17.42 ± 3.58 | |
t | 27.141 | 53.830 | 52.858 | |
P | 0.000 | 0.000 | 0.000 | |
Meloxicam group | Before treatment | 18.31 ± 3.25 | 7.82 ± 0.26 | 35.86 ± 4.36 |
After treatment | 5.16 ± 1.59 | 2.42 ± 0.19 | 20.16 ± 3.45 | |
t | 25.426 | 57.876 | 29.644 | |
P | 0.000 | 0.000 | 0.000 | |
Comparison of the two groups before treatment | t | 8.643 | 18.094 | 0.751 |
P | 0.000 | 0.000 | 0.453 | |
Comparison of the two groups after treatment | t | 11.006 | 12.114 | 12.379 |
P | 0.000 | 0.000 | 0.000 |
- Citation: Hu CX, Hu KY, Wang JF. Potential role of the compound Eucommia bone tonic granules in patients with osteoarthritis and osteonecrosis: A retrospective study. World J Clin Cases 2020; 8(1): 46-53
- URL: https://www.wjgnet.com/2307-8960/full/v8/i1/46.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i1.46